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Instructions for AuthorsThe Journal of the American College of Cardiology (JACC) publishes peer-
reviewed articles highlighting all aspects of cardiovascular disease,
including original clinical studies, experimental investigations with clear
clinical relevance, state-of-the-art papers, and viewpoints. In general, case
reports will not be considered for publication.
We request that all manuscripts be submitted online at www.
jaccsubmit.org. If the manuscript absolutely cannot be submitted
online, please contact the editorial office at jaccsd@acc.org.
Manuscript submissions should conform to the guidelines set forth in
the ‘‘Uniform Requirements for Manuscripts Submitted to Biomedical
Journals: Writing and Editing for Biomedical Publication,’’ available
from http://www.ICMJE.org and most recently updated in April 2010.
English language help service: Upon request, Elsevier will direct
authors to an agent who can check and improve the English of their
paper (before submission). Please contact authorsupport@elsevier.com
for further information.
AUTHOR ENQUIRIES
For enquiries relating to submitted articles or to articles currently under
review, please contact the Journal’s editorial office at jaccsd@acc.org. For
information on articles that have been accepted for publication, please
visit Elsevier’s Authors Home at www.elsevier.com/authors. Elsevier’s
Authors Home also provides the facility to track accepted articles and set
up e-mail alerts to inform you of when an article’s status has changed, as
well as detailed artwork guidelines, copyright information, frequently
asked questions, and more. Authors can order copies of the issue in
which their article appears at a discounted rate. For this service, please
contact Elsevier Health Sciences Division, Subscription Customer
Service, 3251 Riverport Lane, Maryland Heights, MO 63043. Tel:
1-800-6542452, E-mail: journalscustomerservice-usa@elsevier.com.
EXCLUSIVE SUBMISSION/PUBLICATION POLICY
Themanuscripts are considered for review only under the conditions that
they are not under consideration elsewhere and that the data presented
have not appeared on the Internet or have not been previously published
(including symposia, proceedings, transactions, books, articles published
by invitation, and preliminary publications of any kind, excepting
abstracts that do not exceed 400 words). On acceptance, transfer of
copyright to the American College of Cardiology Foundation will be
required. Elsevier Inc. will maintain copyright records for the College.
Only authors appearing on the final title page will be sent a form.
YOU CANNOT ADD AUTHORS AFTER ACCEPTANCE OR
ON PROOFS. After a paper is sent to the publisher, the links to the
electronic forms will no longer be active. In this case, authors will be sent
links to download hard copy forms that they may mail or fax to the
JACC office.
OPEN ACCESS (NEW)
While this journal does not ordinarily have publication charges, authors
can now opt to make their articles available to all (including non-
subscribers) via the ScienceDirect platform, which carries a fee of US
$3,000. (For further information on open access, visit http://www.
elsevier.com/about/open-access/open-access-options). To avoid any
perception of conflict of interest, you can only make this choice after
receiving notification that your article has been accepted for publication.
The fee excludes taxes and other potential costs such as color charges. In
some cases, institutions and funding bodies have entered into agreement
with Elsevier to meet these fees on behalf of their authors. Details of
these agreements are available at http://www.elsevier.com/
fundingbodies. Authors of accepted articles who wish to take advan-
tage of this option should complete and submit the order form, which is
available at http://www.elsevier.com/locate/openaccessform.pdf. What-
ever access option you choose, you retain many rights as an author,
including the right to post a revised personal version of your article on
your own website. More information can be found here: http://www.
elsevier.com/authorsrights. Your publication choice will have no effect
on the peer review process or acceptance of submitted articles.
RELATIONSHIP WITH INDUSTRY POLICY
Authors are required to disclose any relationship with industry and
financial associations within the past 2 years that might pose a confiict of
interest in connection with the submitted article in both the cover letter
and on the title page. All sources of funding for the work should be
acknowledged on the title page, as should all institutional affiliations ofthe authors (including corporate appointments). Other associations,
such as consultancies, stock ownership, or other equity interests or
patent-licensing arrangements, should be disclosed to the editors in the
cover letter at the time of submission. If no relationship with industry
exists, please state this in the cover letter and on the title page. Rela-
tionship with industry guidelines apply to authors of all the following:
Original Research Papers, State-of-the-Art Papers, Expedited Reviews,
Editorials and Viewpoints, Research Correspondence, and Editorial
Comments.
ALL FORMS ARE NOW SIGNED AND SUBMITTED ELEC-
TRONICALLY. Once a manuscript is accepted, the authors will be sent
links to complete electronic Copyright Transfer and Relationship with
Industry forms. Only the corresponding author may electronically sign
the copyright form; however, ALL AUTHORS ARE REQUIRED
TO ELECTRONICALLY SIGN A RELATIONSHIP WITH
INDUSTRY FORM. Once completed, a PDF version of the form is
e-mailed to the author. Authors can access and confirm receipt of forms
by logging into their account online. Each author will be alerted if his
form has not been completed by the deadline.
PERMISSIONS
No part of materials published in JACC may be reproduced without
written permission of the publisher. Some materials qualify for gratis
usage. See STM Guidelines for details: http://www.stm-assoc.org/
permissions-guidelines/. Permission may be sought directly from
Elsevier’s Global Rights Department. Phone: 215-239-3804 or 441865-
843-830. Fax: 44-1865-853-333. Requests also may be completed
online via the Elsevier site (http://www.elsevier.com/authors/obtaining
permission-to-re-use-elsevier-material).
ETHICS
Studies should be in compliance with human studies committees and
animal welfare regulations of the authors’ institutions and the U.S. Food
and Drug Administration guidelines.
Human studies must be performed with the subjects’ written
informed consent. Authors must provide the details of this procedure
and indicate that the institutional committee on human research has
approved the study protocol. If radiation is used in a research procedure,
the radiation exposure must be specified in the Methods.
Studies on patients or volunteers require ethics committee approval
and informed consent, which should be documented in your paper.
Patients have a right to privacy. Therefore, identifying information,
including patients’ images, names, initials, or hospital numbers, should
not be included in videos, recordings, written descriptions, photographs,
and pedigrees unless the information is essential for scientific purposes,
and you have obtained written informed consent for publication in print
and electronic form from the patient (or parent, guardian, next of kin or
other legally authorized representative). If consent is subject to condi-
tions, the editorial office must be informed.
Written consents must be provided to the editorial office on request.
Even where consent has been given, identifying details should be
omitted if they are not essential. If identifying characteristics are altered
to protect anonymity, such as in genetic pedigrees, authors should
provide assurance that alterations do not distort scientific meaning and
editors should so note. If such consent has not been obtained, personal
details of patients included in any part of the paper and in any
supplementary materials (including all illustrations and videos) must be
removed before submission.
Animal investigation must conform to the ‘‘Position of the American
Heart Association on Research Animal Use,’’ adopted by the AHA on
November 11, 1984. If equivalent guidelines are used, they should be
indicated. The AHA position includes: 1) animal care and use by
qualified individuals, supervised by veterinarians, and all facilities and
transportation must comply with current legal requirements and
guide-lines; 2) research involving animals should be done only when
alternative methods to yield needed information are not possible;
3) anesthesia must be used in all surgical interventions, all unnecessary
suffering should be avoided and research must be terminated if
unnecessary pain or fear results; and 4) animal facilities must meet the
standards of the American Association for Accreditation of Laboratory
Animal Care (AAALAC).
JACC has an ethics committee comprised of 5 cardiologists, which
oversees quality control and will look into any issues of concern.
AUTHORSHIP/COVER LETTER
Each author must have contributed significantly to the submitted work.
If there are more than 4 authors, the contribution of each must be
substantiated in the cover letter. If authorship is attributed to a group
(either solely or in addition to 1 or more individual authors), all
members of the group must meet the full criteria and requirements for
authorship. To save space, if group members have been listed in JACC,
the article should be referenced rather than reprinting the list. The
editors consider authorship to include all of the following: 1) conception
and design or analysis and interpretation of data, or both; 2) drafting of
the manuscript or revising it critically for important intellectual content;
and 3) final approval of the manuscript submitted. Participation solely
in the collection of data does not justify authorship but may be
appropriately acknowledged in the Acknowledgment section.
Manuscripts must be submitted with a cover letter stating that: 1) the
paper is not under consideration elsewhere; 2) none of the paper’s
contents have been previously published; 3) all authors have read and
approved the manuscript; 4) the full disclosure of any relationship with
industry (see “Relationship with Industry Policy”); and 5) the authors
have provided both an illustration and the appropriate material for
inclusion in the box that appears after the “Conclusions” section in the
manuscript. Exceptions must be explained.
The corresponding author should be specified in the cover letter. All
editorial communications will be sent to this author. The corresponding
author will be whom we contact for submission queries.
A short paragraph telling the editors why the authors think their
paper merits publication priority may be included in the cover letter.
Potential reviewers may be suggested in the cover letter, as well as
reviewers to avoid.
GENERAL GUIDELINES FOR SUBMISSION
OF REVIEW ARTICLES
Although the review articles are invited manuscripts, we will happily
consider high-caliber proposals. Please submit a pre-submission inquiry
before you submit your manuscript. After the manuscript is accepted for
publication, the JACC editors will support the development of the
review articles, and the professional JACC illustrators will redraw illus-
trations. The review articles are considered for publication in the
following two formats.
1) Present and Future – State-of-the-Art Review: As with all
submissions to JACC, State-of-the-Art Reviews should focus on the
patient. From basic mechanisms to clinical manifestations and inter-
ventional approaches to global health implications, such manuscripts
will focus on a contemporary, controversial, or translational topic with
4–5 major sections written by 4–5 authors (or 4–5 author groups). This
should be submitted as 1 single, unified paper, and not as 4–5 individual
manuscripts. The authors should strictly adhere to the text length
guidelines (where each section is restricted to 1,500–2,000 words with
a 10,000-word maximum limit for the entire manuscript). These
manuscripts carry an introductory piece limited to 750–1,000 words.
The manuscripts also can be formatted as point-counterpoint debates,
which require an unstructured abstract of no more than 150 words. We
ask authors to provide a schematic illustration that summarizes the
review (at most, one per section). If the manuscript is accepted, the final
figure would be drawn by an in-house artist.
2) Present and Future – Review Topic of the Week: As with all
submissions to JACC, Review Topics of the Week should focus on the
patient. These articles review a contemporary topic of basic, translational,
or clinical science. Please e-mail the proposal to the office before
submitting your paper (jaccsd@acc.org). Such manuscripts may be
written by a single author or an author group, and requires an
unstructured abstract of no more than 150 words. The overall text length
should not exceed 5,000 words. We ask you to provide a schematic (line
or pictorial) illustration that summarizes the review. If the manuscript is
accepted, the final figure will be drawn by an in-house artist.
GENERAL GUIDELINES FOR SUBMISSION
OF ORIGINAL RESEARCH PAPERS
Because of printed page limitations, manuscripts should not exceed
5,000 words (including references and figure legends). If you are asked
to revise your paper, the editors may specify an alternate word limit.
Illustrations and tables should be limited to those necessary to highlight
key data. Please provide gender-specific data, when appropriate, in
describing outcomes of epidemiologic analyses or clinical trials; or
specifically state that there were no gender-based differences. For original
research dealing with genetic associations, authors should refer to J Am
Coll Cardiol 2007;50:930–2.
The manuscript should be arranged as follows: 1) Title page;
2) Structured Abstract and key words; 3) Abbreviations list; 4) text;5) Perspectives [New Feature]: Core Clinical Competencies and
Translational Implications; they are presented on a separate page and
will be published in a box, 6) Acknowledgments (if applicable);
7) References; 8) Figure titles and legends; 9) tables. Page numbering
should begin with the title page. Authors are required to make one figure
as an illustration that summarizes the main point of the paper. This may
be a sketchor afinishedfigure.The JACC staff illustrator can assist you free
of charge in finishing the figure, if the paper is accepted for publication.
Expedited Publications. Original manuscripts in this category
should report important original findings of high-potential clinical
impact or research significance. They can be either a full-length paper or
a short report presenting early findings. Authors should request expe-
dited publication in their cover letter at the time of submission. The
editors commit to a decision regarding suitability for expedited publi-
cation processing within 2 days, and an initial decision within 14 days.
Those manuscripts not deemed appropriate for the expedited publica-
tion track will be considered according to the standard review process.
We always inform authors whether we are able to offer expedited review.
MANUSCRIPT CONTENT
COVER PAGE. Include the title, authors’ names (including full first
name, middle initial and degrees), total word count, and a brief title of
no more than 45 characters. List the departments and institutions with
which the authors are affiliated, and indicate the specific affiliations if
the work is generated from more than one institution. (Use the footnote
symbols given under “Tables”.) Also provide information on grants,
contracts, and other forms of financial support, and list the cities and
states of all foundations, funds and institutions involved in the work.
Include any relationship with industry. (See the “Relationship with
Industry Policy”.) If there are no relationships with industry, this should
be stated. Under the heading, “Address for correspondence,” provide the
full name and complete postal address of the author to whom
communications, printer’s proofs, and reprint requests should be sent.
Also provide telephone, fax numbers and an e-mail address.
STRUCTURED ABSTRACT. Provide a structured abstract between
250 (min)–300 (max) words, presenting essential data in 5 paragraphs
introduced by separate headings in the following order: Background,
Objectives, Methods, Results, and Conclusions. Please notice the change
in the sequence of headings compared to what we used to publish
earlier; now Background precedes Objectives. Use complete sentences. All
data in the abstract also must appear in the manuscript text or tables.
For general information on preparing structured abstracts, see
‘‘Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More
informative abstracts revisited. Ann Intern Med 1990;113:69–76.’’ An
unstructured 150-word abstract should be provided for the review
articles.
KEYWORDS. Immediately after the perspectives, provide a maximum
of 6 keywords, using American spelling and avoiding general and plural
terms and multiple concepts (avoid, for example, ‘and’, ‘of’). Be sparing
with abbreviations. These keywords will be used for indexing purposes,
and therefore should be different then the terms/words already used in
the title of the paper.
TEXT. The text should be structured as Introduction, Methods,
Results, Discussion, and Conclusions. Use headings and subheadings in
the Methods, Results, and, particularly in the Discussion sections. Every
reference, figure, and table should be cited in the text in numerical order
according to order of mention.
To save space in the Journal, up to 10 abbreviations of common
terms (e.g., ECG, PTCA, CABG) or acronyms (GUSTO, SOLVD,
TIMI) may be used throughout the manuscript. On a separate page
following the abstract, list the selected abbreviations and their definitions
(e.g., TEE ¼ transesophageal echocardiography). The editors will
determine which lesser-known terms should not be abbreviated. Authors
should consider using only the most common abbreviations in their
Conclusions section. Consult ‘‘Uniform Requirements for Manuscripts
Submitted to Biomedical Journals: Writing and Editing for Biomedical
Publication,’’ available at http://www.ICMJE.org and most recently
updated in April 2010, for appropriate use of units of measure.
STATISTICS. All publishable manuscripts will be reviewed for
appropriateness and accuracy of statistical methods and statistical
interpretation of results. We subscribe to the statistics section of the
“Uniform Requirements for Manuscripts Submitted to Biomedical
Journals: Writing and Editing for Biomedical Publication,” available at
http://www.ICMJE.org and most recently updated in April 2010. In the
Methods section, provide a subsection detailing the statistical methods,
including specific methods used to summarize the data, methods used
for hypothesis testing (if any), and the level of significance used for
hypothesis testing. When using more sophisticated statistical methods
(beyond t tests, chi-square, simple linear regression), specify the statis-
tical package, version number, and nondefault options used. For more
information on statistical review, see ‘‘Glantz SA. It is all in the
numbers. J Am Coll Cardiol 1993;21:835–7.’’
PERSPECTIVES [NEW FEATURE]. The authors should delineate
clinical competencies and translational outlook recommendations for
their manuscripts. These should be listed in the manuscript after the Text
and before the Acknowledgments and References. Please review the
examples provided below. The competencies describe the implications of
the study for current practice. The translational outlook places the work
in a futuristic context, emphasizing directions for additional research.
Clinical Competencies. Competency-based learning in cardiovas-
cular medicine addresses the 6 domains promulgated by the Accredi-
tation Council on Graduate Medical Education (ACGME) and
endorsed by the American Board of Internal Medicine (Medical
Knowledge, Patient Care and Procedural Skills, Interpersonal and
Communication Skills, Systems-Based Practice, Practice-Based
Learning, and Professionalism) (www.acgme.org/acgmeweb). The ACCF
has adopted this format for its competency and training statements,
career milestones, lifelong learning, and educational programs. The
ACCF also has developed tools to assist physicians in assessing,
enhancing, and documenting these competencies (www.cardiosource.org/
Lifelong-Learning-and-MOC/Resources/Competencies). Authors are asked
to consider the clinical implications of their report and identify appli-
cations in one or more these competency domains that could be used by
clinician readers to enhance their competency as professional caregivers.
This applies not only to physicians in training, but to the sustained
commitment to education and continuous improvement across the span
of their professional careers.
Translational Outlook. Translating biomedical research from the
laboratory bench, clinical trials or global observations to the care of
individual patients can expedite discovery of new diagnostic tools and
treatments through multidisciplinary collaboration. Effective trans-
lational medicine facilitates implementation of evolving strategies for
prevention and treatment of disease in the community. The Institute of
Medicine identified two areas needing improvement: testing basic
research findings in properly designed clinical trials and, once the safety
and efficacy of an intervention has been confirmed, more efficiently
promulgating its adoption into standard practice (Sung NS, Crowley WF,
Genel M. The meaning of translational research and why it matters. JAMA
2008;299:3140–3148). The National Institutes of Health (NIH) has
recognized the importance of translational biomedical research,
emphasizing multifunctional collaborations between researchers and
clinicians to leverage new technology and accelerate the delivery of new
therapies to patients (www.ncats.nih.gov/about/about.html). Authors are
asked to place their work in the context of the scientific continuum, by
identifying impediments and challenges requiring further investigation
and anticipating next steps and directions for future research.
EXAMPLE 1: For a Clinical Trial [N Engl J Med 2012;367:
2375–84]:
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Coronary artery
bypass (CABG) surgery is the preferred method of revascularization for
patients with diabetes and multivessel coronary artery disease.
COMPETENCY IN PATIENT CARE: The diabetic patient with
coronary symptomatology, prior to the diagnostic catheterization,
should be made aware that if multivessel disease is identified and
intervention is indicated, surgical consultation should be entertained.
TRANSLATIONAL OUTLOOK 1: Although this is a relatively short-
term study (median of 3.8 years), longer term follow up of FREEDOM
will lead to better understanding of the comparative benefit by CABG,
specifically on mortality.
TRANSLATIONAL OUTLOOK 2: Compliance to medication is
non-satisfactory in patients with coronary artery disease. Comparing the
compliance of FREEDOM patients taking a “polypill” approach
(including aspirin, statin, and an angiotensin converting enzyme
inhibitor) with the compliance of patients treated conventionally with
individual agents should be undertaken.
EXAMPLE 2: For a Translational Science Study [Nat Med
2014;20:215–9]:
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Inflammation is
one of the major determinants of atherosclerotic plaque instability.Positron emission tomography with F18-labeled fluorodeoxyglucose
(FDG) has been employed for the identification of the macrophages in
high-risk patients. Imaging with mannose, the isomer of glucose may
have an advantage because a subset of macrophages in high-risk plaques
develop mannose receptors.
TRANSLATIONAL OUTLOOK 1: Although circulating biomarkers
of inflammation, such as hs-CRP provide reliable information of
systemic inflammation, detection of inflammation at the plaque level
may allow identification of the high-risk plaques.
TRANSLATIONAL OUTLOOK 2: Plaque imaging with sugars,
although feasible, must in a randomized fashion investigate whether
treatment of individual high-risk plaques would favorably influence
major adverse outcomes in atherosclerotic disease.
EXAMPLE 3: For a Meta Analysis or a Review Article [Lancet
2014;383:955–62]:
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE 1: Selection of
antithrombotic therapy for prevention of thromboembolism in patients
with atrial fibrillation must consider several clinical factors, including the
patient’s values and preferences.
COMPETENCY IN MEDICAL KNOWLEDGE 2: The oral direct
thrombin inhibitor, dabigatran, and factor Xa inhibitors rivaroxaban,
apixaban and edoxaban (so-called novel oral anticoagulants or NOACs)
avoid the dietary restrictions and need for routine coagulation moni-
toring that are cumbersome aspects of anticoagulation with vitamin K
antagonists such as warfarin.
COMPETENCY IN PATIENT CARE: All three NOACs currently
approved for clinical use in the U.S. represent advances over warfarin
because of their more predictable pharmacological profiles, fewer drug
interactions, and considerably lower risk of intracranial bleeding than
warfarin, but these advantages come at greater monetary cost, and there
is presently no approved antidote or validated strategy rapid reversal of
anticoagulation induced by any of the NOACs.
COMPETENCY IN INTERPERSONAL & COMMUNICATION
SKILLS: It is important to discuss the available options with patients
who are candidates for the newer agents.
TRANSLATIONAL OUTLOOK 1: The mechanism by which each of
the NOACs evaluated to date cause less intracerebral hemorrhage than
well managed warfarin anticoagulation requires further investigation.
TRANSLATIONAL OUTLOOK 2: Additional research is needed to
understand the safety and efficacy of the NOACs, alone or in combi-
nation in patients with mechanical prosthetic heart valves to overcome
the toxicity of this type of anticoagulation in the limited studies
undertaken to date that contraindicate their use in patients who have
undergone heart valve replacement with mechanical prostheses.
ACKNOWLEDGMENTS. 100 words or less; anything exceeding this
limit will appear in the online version only. Letters of permission from
all individuals listed in the acknowledgments are the responsibility of the
corresponding author.
OTHER PAPER CATEGORIES
The following information should be noted for these paper types:
Editorial Comments. The editors invite all Editorial Comments pub-
lished in the Journal.
Correspondence. A limited number of letters will be published. The
letters are of two types.
1) They should focus on a specific article that has appeared in JACC.
Letters must be submitted within 3 months of the print issue date of the
article. Please include the cited article as a reference. We may seek a reply
to your letter from the authors of the original paper and publish together.
2) You also may submit original research articles of a focused nature as
Research Correspondence. These correspondence articles are limited to
a total of 800 words including references (no more than 5), and to one
figure or table. The letters should include double-spaced type. Provide
a title page that includes the name(s) of the author(s) and institutional
affiliations and a complete address for correspondence. These can be
submitted online at www.jaccsubmit.org. These papers do not need an
abstract.
REFERENCES
Identify references in the text by Arabic numerals in parentheses on the
line. The reference list should be typed double-spaced on pages separate
from the text; references must be numbered consecutively in the order in
which they are mentioned in the text.
Do not cite personal communications, manuscripts in preparation, or
other unpublished data in the references; these may be cited in the text
in parentheses. Do not cite abstracts that are older than 2 years. Identify
abstracts by the abbreviation ‘‘abstr’’ in parentheses. If letters to the
editor are cited, identify them with the word ‘‘letter’’ in parentheses.
Use Index Medicus (National Library of Medicine) abbreviations for
journal titles. It is important to note that when citing an article from the
Journal of the American College of Cardiology, the correct citation
format is J Am Coll Cardiol.
Use the following style and punctuation for references:
Periodical. List all authors if 6 or fewer, otherwise list the first 3 and
add et al. Do not use periods after the authors’ initials. Please provide
inclusive page numbers as in example below.
5. Glantz SA. It is all in the numbers. J Am Coll Cardiol 1993;21:
835–7.
Doi-based citation for an article in press
If the ahead-of-print date is known, provide as in example below.
16. Winchester D, Wen X, Xie L, et al. Evidence for pre-procedural
statin therapy: meta-analysis of randomized trials. J Am Coll Cardiol
2010 Sept 28 [E-pub ahead of print], http://dx.doi.org/10.1016/j.jacc.
2010.09.028.
If the ahead-of-print date is unknown, omit as in example below.
16. Winchester D, Wen X, Xie L, et al. Evidence for pre-procedural
statin therapy:meta-analysis of randomized trials. J AmCollCardiol 2010
[E-pub ahead of print], http://dx.doi.org/10.1016/j.jacc.2010.09.028.
Chapter in book. Provide author(s), chapter title, editor(s), book title,
publisher location, publisher name, year, and inclusive page numbers.
27. Meidell RS, Gerard RD, Sambrook JF. Molecular biology of
thrombolytic agents. In:RobertsR, editor.Molecular Basis ofCardiology.
Cambridge, MA: Blackwell Scientific Publications, 1993:295–324.
Book (personal author or authors)
Provide a specific (not inclusive) page number.
23. Cohn PF. Silent Myocardial Ischemia and Infarction. 3rd edition.
New York, NY: Marcel Dekker, 1993:33.
Online media. Provide specific URL address and date information
was accessed.
10. Henkel J. Testicular Cancer: Survival High With Early Treat-
ment. FDA Consumer magazine [serial online]. January–February
1996. Available at: http://www.fda.gov/fdac/features/196_test.html.
Accessed August 31, 1998.
Material presented at a meeting but not published. Provide
authors, presentation title, full meeting title, meeting dates, and
meeting location.
20. Eisenberg J. Market forces and physician workforce reform: why
they may not work. Paper presented at: Annual Meeting of the Asso-
ciation of Medical Colleges; October 28, 1995; Washington, DC.
ILLUSTRATIONS, FIGURES & FIGURE LEGENDS
FIGURE LEGENDS. All figures must have a Title and a Caption. The
title should be short and followed by a 2–3 sentence caption. All
abbreviations used in the figure should be identified in an alphabetical
order at the end of each legend. All symbols used (arrows, circles, etc.)
must be explained. Figure legends should be typed double-spaced on
pages separate from the text. Figure numbers must correspond with the
order in which they are mentioned in the text.
If previously published figures are used, written permission from the
original publisher is required. See STM Guidelines for details: http://
www.stmassoc.org/permissions-guidelines/. Cite the source of the
figure in the legend.
ARTWORK. Figures and graphs submitted in electronic format should
be provided in EPS or TIF format. Graphics software such as Photo-
shop and Illustrator should be used to create the art, but not presen-
tation software such as Powerpoint, CorelDraw, or Harvard Graphics.
Color images must be at least 300 DPI. Gray scale images should be at
least 300 DPI. Line art (black and white or color) and combinations of
gray scale images and line art should be at least 1200 DPI. Lettering
should be of sufficient size to be legible after reduction for publication.
The optimal size is 12 points. Symbols should be of a similar size.
Figures should be no smaller than 13 cm 18 cm (5” 7”). Decimals,
lines, and other details must be strong enough for reproduction. Use
only black and whitednot graydin charts and graphs. Place crop
marks on photomicrographs to show only the essential field. Designate
special features with arrows. All symbols, arrows, and lettering on half-
tone illustrations must contrast with the background.
The in-house artist would tweak the figures and re-size the figures if
needed.NON-ELECTRONIC ARTWORK. Upon provisional acceptance, we
may request 2 sets of glossy or laser prints (clean copies will suffice).
Two sets of glossy prints should be provided for all half-tone or color
illustrations. All graphs and line drawings must be professionally
prepared on a computer and reproduced as high-quality laser prints.
Indicate the first author’s last name (and the corresponding author’s last
name within parentheses, if different) and the figure number on the
back of each figure, preferably on an adhesive label. Figure title and
caption material must appear in the legend, not on the figure.
Note: if we request hardcopies, they will not be returned to authors.
COLOR ARTWORK. There is no fee for the publication of color
figures. Our editors encourage authors to submit figures in color, as we
feel it improves the clarity and visual impact of the images.
CENTRAL ILLUSTRATION [NEW FEATURE]. All original
investigations, state-of-the-art reviews and review topics should develop
at least 1 central illustration drawing or figure (that may be a simple/
rough hand-drawn figure), which summarizes the entire manuscript or
at least a major section of the manuscript. Our in-house medical illus-
trators will create the final printable versions of these figures in
consultation with the authors and the editors. The purpose of these
illustrations is to provide a snapshot of your paper in a single visual,
conceptual manner. This illustration must be accompanied by a legend.
TABLES
Tables should be typed double-spaced on separate sheets, with the table
number and title centered above the table and explanatory notes below
the table. Use Arabic numbers. Table numbers must correspond with
the order cited in the text.
ALL TABLES MUST HAVE A TITLE.
Abbreviations should be listed in a footnote under the table in
alphabetical order. Footnote symbols should appear in the following
order: *, y, z, x, k, {, #, yy, zz, etc.
Tables should be self-explanatory, and the data presented in them
should not be duplicated in the text or figures. If previously published
tables are used, written permission from the original publisher and
author is required. Cite the source of the table in the footnote.
VIDEO REQUIREMENTS
Inclusion of videos in the published paper is at the discretion of the editors.
1. Video submissions for viewing online should be one of the following
formats: AudioVideo Interleave (.avi), MPEG (.mpg), or QuickTime
(.qt, .mov).
AVI files can be displayed via Windows Media Player MPEG files
can be displayed via Windows Media Player
http://www.microsoft.com/windows/windowsmedia/
http://www.microsoft.com/windows/windowsmedia/players.aspx
QuickTime files require QuickTime software (free) from Apple
http://www.apple.com/quicktime/download/index.html
2. Videos should be brief whenever possible (<2–5 min). Longer videos
will require longer download times and may have difficulty playing
online. Videos should be restricted to the most critical aspects of your
research. A longer procedure can be restructured as several shorter videos
and submitted in that form.
3. It is advisable to compress files to use as little bandwidth as possible
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